Previous chapter:
Chapter 112: Plant-based Pharmaceuticals (5)
Next chapter:
Chapter 114: The Royal Swedish Academy of Sciences (1)
PREVIEW
... issue. There was also a debate in the public over whether it could be viewed as an insurance product or not. It was because the insurance business A-Gen Life started was very different compared to the existing insurance business in many ways.
They were selling a unique product to high-risk people who existing insurance companies would not take. The price of diagnostic kits was included in the premium, and the customer would pay the premium.
If the customer self-diagnosed with the ...
YOU MAY ALSO LIKE